Windlas Biotech Limited (formerly known as Windlas Biotech Private Limited) was incorporated in 2001. The Company convertedfrom a Private Limited Company to a Public Limited Company and the name ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

About Purple Biotech Purple Biotech Ltd. (NASDAQ/TASE: PPBT) is a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance.

PITTSBURGH, May 06, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today reported financial results for the first quarter ending March 31, 2025 and provided a ...

The first shards of hu­man da­ta on in vi­vo CAR-T cell ther­a­py look promis­ing, based on re­cent sep­a­rate re­ports from two biotech com­pa­nies’ aca­d­e­m­ic-led stud­ies … ...

Deerfield Management has unveiled the third installment of its healthcare innovations fund, earmarking more than $600 million for promising therapeutics and technologies. The funds will also go ...

Those investments were tallied during a recalibration of biotech venture funding, with venture firms coalescing around a smaller number of surer bets that often come in the form of $100 million-plus ...

Delaney’s committee roles suggest potential informational advantages in biotech-related decisions. Finbold’s congressional trading radar has recently picked up a suspicious stock bet made by Maryland ...

Buckner was speaking last month at Life Science Innovation Northwest, Seattle’s marquee gathering of the biotech industry. Most years, the two-day conference sees scientists, investors and other ...

Pliant Therapeutics, a South San Francisco biotech company developing treatments for fibrosis, is slashing its staff after halting a crucial study over safety concerns. This layoff round arrives ...